A paper published online yesterday in Nature (and ‘leaked’ a week ago by the MIT Technology Review) describes the use of CRISPR in human embryos to correct a mutation that causes hypertrophic cardiomyopathy. The work has hit the headlines and sparked debate about its utility and implications.
Collated below are responses from the field (or at least, those of them on Twitter!) and links to opinion pieces. If we missed any links, let us know and we’ll update.
We’d also love to hear your thoughts on the work – use the comment section below.